Barclays raised the firm’s price target on Keurig Dr Pepper to $36 from $34 and keeps an Overweight rating on the shares. The analyst says that despite growing concerns heading into the print, Keurig’s outlook for both 2023 and 2024 are intact.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on KDP:
- Keurig Dr Pepper price target lowered to $33 from $35 at Goldman Sachs
- Keurig Dr Pepper (NASDAQ:KDP) Rises on Healthy Q3 Performance
- Keurig Dr Pepper, Grupo PiSA announce Electrolit distribution partnership
- Keurig Dr Pepper Reports Q3 2023 Results and Reaffirms Full Year Guidance
- Keurig Dr Pepper backs FY23 adjusted EPS growth 6%-7%, consensus $1.78
